Susan Dexter, CTO at Sonnet BioTherapeutics Holdings, holds 33.67K shares in Sonnet BioTherapeutics Holdings (Ticker: SONN). Most recently, Susan Dexter Bought $10,000 shares of Sonnet BioTherapeutics Holdings on Jun 15, 2023 for an estimated value of 7.00K.